Jasper Therapeutics, Inc.

Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.

JSPR | NDAQ

Overview

Corporate Details

ISIN(s):: US4718712023 (+3 more)
LEI:
Country:: United States of America
Address:: 2200 BRIDGE PKWY SUITE #102, 94065 REDWOOD CITY
Website:: https://jaspertx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for mast cell-driven diseases and as a conditioning agent for hematopoietic stem cell transplantation. The company's lead product candidate is briquilimab, a targeted anti-KIT (CD117) monoclonal antibody designed to deplete mast cells. Jasper is evaluating briquilimab in clinical studies for the treatment of chronic immunological and inflammatory diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to develop safer and more effective therapies for patients with serious chronic diseases by harnessing the power of mast cell depletion.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Jasper Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Jasper Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Jasper Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Biovica International B Develops blood tests to monitor the efficacy of solid tumor cancer therapies.	Sweden	BIOVIC
BIOVIE INC. Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.	United States of America	BIVI
BioXcel Therapeutics, Inc. AI-driven biopharma developing treatments for neuroscience and immuno-oncology.	United States of America	BTAI
Black Diamond Therapeutics, Inc. Develops precision oncology drugs targeting mutation families in lung and brain cancers.	United States of America	BDTX
BL Pharmtech Corp. Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.	South Korea	065170
BOIRON Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.	France	BOI
Bon Natural Life Ltd Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.	United States of America	BON
Bosnalijek d.d. Sarajevo Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.	Bosnia and Herzegovina	BSNL
Boundless Bio, Inc. Developing ecDNA-directed therapies for intractable oncogene amplified cancers.	United States of America	BOLD
BridgeBio Oncology Therapeutics, Inc. Clinical-stage biopharma creating small molecule drugs for RAS-dependent cancers.	United States of America	BBOT